Coagulation therapy in hemophilia A and its relation to factor VIII inhibitor in Northeast of Iran [2]

Iranian Journal of Medical Sciences

Volumn 29, Issue 4, 2004, Pages 199-

  Torghabeh, H Mansouri ^a   Pourfathollah, A A ^a   Shoosshtari, M Mahmoodian ^b   Rezaieyazdi, Z ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; FRESH FROZEN PLASMA;

BLOOD SAMPLING; CRYOPRECIPITATE; DEVELOPING COUNTRY; HEALTH CARE DELIVERY; HEMOPHILIA A; HUMAN; IRAN; LETTER; MAJOR CLINICAL STUDY; QUESTIONNAIRE; X CHROMOSOME LINKED DISORDER;

EID: 20544449607     PISSN: 02530716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Mannuci PM, Tuddenham E. The hemophilia from Royal genes to gene therapy. N Engl J Med 2001; 344: 1773-9.
2. Liras A. Gene therapy for hemophilia: The end of a Royal pathology in the third millennium? Haemophilia 2001; 7: 441-5.
3. Dingli D, Gastineau DA, Gilchrist G, and et al. Continuous factor VIII infusion therapy in patients with hemophila A undergoing surgical procedures with plasma derived or recombinant factor VIII concentrates. Haemophilia 2002; 8: 629-34.
4. Yee TT, Beeton K, Griffioen A. Experience of prophylaxis treatment in children with severe hemophilia. Haemophilia 2002; 8: 76-82.
5. Minor PD. Are recombinant products really infection risk free? Haemophilia. 2001; 7: 114-7.
6. Maansouri Torghabeh H, Pourfathollah AA, Mahmoodian Shooshtari M, Rezaie Yazdi Z, et al. Evaluation pattern of factor VIII inhibitor in patients with hemophilia A in Khorasan. Hakim J 2004; 8: 1-5.